Business
Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment
LifeSci Global Launches as Reliance’s Life Sciences Platform, Partnering with Scott Korman and David Turner as Its Founding Operator-Partners to Build, Lead and Grow the Platform Korman and Turner Bring Complementary Decades of Private Equity, Capital Markets, Healthcare and Company-Building Expertise to Anchor the Platform; Innervate Provides Exposure to Estimated $250 Million Neuroblastoma Opportunity, Potential Expansion Opportunities in Additional Disease Areas and Priority Review Voucher Up
About this update from Reliance Global Group, Inc.
[{"type":"image","alt":"Reliance Global Group, Inc.","displaySize":"","headline":null,"caption":"Reliance Global Group, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":66,"url":"https://media.zenfs.com/en/globenewswire.com/38353f0f7188eeb85b6c314c4699c386"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yEg_E33i1mRNiCm2E99zgA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTky/https://media.zenfs.com/en/globenewswire.com/38353f0f7188eeb85b6c314c4699c386","width":300,"height":66}},"lazy":false},{"type":"text","content":"LifeSci Global Launches as Reliance’s Life Sciences Platform, Partnering with Scott Korman and David Turner as Its Founding Operator-Partners to Build, Lead and Grow the Platform","length":178,"tagName":"p"},{"type":"text","content":"Korman and Turner Bring Complementary Decades of Private Equity, Capital Markets, Healthcare and Company-Building Expertise to Anchor the Platform; Innervate Provides Exposure to Estimated $250 Million Neuroblastoma Opportunity, Potential Expansion Opportunities in Additional Disease Areas and Priority Review Voucher Upside","length":325,"tagName":"p"},{"type":"text","content":"LAKEWOOD, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) (“we,” “us,” “our,” the “Company” or “Reliance”) today announced the formal launch of LifeSci Global Group LLC (“LifeSci Global”), its dedicated life sciences and biotechnology platform, co-founded alongside Scott Korman and David Turner, who will serve as the platform’s founding operator-partners and lead all aspects of its build-out and growth. LifeSci Global is a subsidiary of EZRA International Group, Reliance’s strategic growth platform focused on building and investing in high-growth technology and life sciences companies. In connection with this launch, Reliance is also announcing Innervate Radiopharmaceuticals as LifeSci Global’s first platform investment.","length":764,"tagName":"p"},{"type":"text","content":"The launch of LifeSci Global reflects Reliance’s studio model: rather than making passive investments, Reliance identifies compelling verticals, launches a dedicated platform, and partners with exceptional proven operators who possess the domain expertise to build great companies from the ground up. Scott Korman and David Turner are those operators for the life sciences vertical. They bring complemen...